Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Intermittent Fasting for NAFLD in Adults [NA]
A clinical trial is recruiting to evaluate intermittent fasting as an intervention for non-alcoholic fatty liver disease in adults.
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: NAFLD in Diabetes Type 2 in Primary Care
This update reports the completion of a clinical trial examining non-alcoholic fatty liver disease in adults with type 2 diabetes in a prima…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED [NA]
Northwestern University is leading a trial protocol to improve diagnostic safety for fatty liver disease by identifying steatosis, risk stra…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis [NA]
This trial update describes the development of a quantifiable ultrasound biomarker for hepatic steatosis (fatty liver) with ongoing recruitm…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes
Clinical trial evaluating whether SGLT2 inhibitor therapy affects elastographic and molecular markers of liver injury in patients with type …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices
A completed clinical trial evaluating hepatic steatosis assessment using dedicated ultrasound software implemented on ultrasound devices.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease [Phase 1]
Phase 1 study evaluating tolerability of multiple doses of BI 3006337 in adults with obesity and non-alcoholic fatty liver disease; the tria…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
This clinical trial update describes the FLiPP (Non-alcoholic Fatty Liver Disease Parametric PET) study evaluating PET imaging for NAFLD and…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease [NA]
Clinical trial update describing a study evaluating the efficacy and adherence of an Adapted Physical Activity program for patients with non…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) [NA]
This clinical trial update outlines a physiologic analysis of Endoscopic Sleeve Gastroplasty (ESG). It addresses conditions including non-al…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial [NA]
A randomized controlled trial is recruiting to evaluate endoscopic sleeve gastroplasty for obesity in patients with MASLD/MASH and related l…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Repeatability and Reproducibility of Multiparametric MRI
A clinical trial update reports on the repeatability and reproducibility of multiparametric MRI for evaluating liver diseases across several…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Screening for NAFLD in Flanders [NA]
Hasselt University is conducting a screening study for non-alcoholic fatty liver disease in Flanders, and the trial is currently active but …
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Economic Burden of NAFLD [NA]
A Hasselt University study on the economic burden of non-alcoholic fatty liver disease (NAFLD) has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Treating PCOS With Semaglutide vs Active Lifestyle Intervention [Phase 2, Phase 3]
Phase 2/Phase 3 trial comparing semaglutide to active lifestyle intervention for polycystic ovary syndrome has completed, with results poste…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
The document reports a recruiting clinical trial from Chang Gung Memorial Hospital evaluating integrative multi-omics approaches across meta…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
A community-based prospective cohort study is investigating metabolic dysfunction-associated fatty liver disease in older adults to understa…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk [Phase 2]
Phase 2 results have been posted for a growth hormone releasing hormone analog aimed at improving non-alcoholic fatty liver disease and asso…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity [NA]
A completed clinical trial from Universidad de Granada evaluated time-restricted eating and exercise on cardiometabolic health in individual…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH) [NA]
A clinical trial using human liver organoids to study the development of non-alcoholic steatohepatitis, with NAFLD listed as the condition, …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease. [NA]
Clinical trial update describing a chrononutrition/chronotoxicity intervention for MASLD (metabolic dysfunction-associated steatotic liver d…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD [NA]
A clinical trial comparing two non-invasive strategies to diagnose advanced liver fibrosis in non-alcoholic fatty liver disease; currently r…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB) [Phase 2]
A Phase 2 clinical trial (NICOFIB) is evaluating the efficacy and safety of nicotinamide in patients with liver fibrosis, with recruitment o…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: The Liver BIoBank Lombardia of Fatty Liver [NA]
A recruiting clinical trial in Lombardy, Italy, collecting liver samples for fatty liver disease (NAFLD) under the Liver Biobank Lombardia, …
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus [NA]
This completed clinical trial evaluated blood-test screening for liver fibrosis in people with Type 2 diabetes mellitus. The study included …